Oncternal Therapeutics
1 follower
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.
Org chart
James Breitmeyer
President & CEO
James Breitmeyer
Collapse
Rajesh Krishnan
Chief Scientific Officer And Chief Technical Officer
Salim Yazji
Chief Medical Officer
Chase Leavitt
General Counsel & Corporate Secretary
Pablo Urbaneja
Senior Vice President, Corporate Development
Anita Wiseth
Senior Vice President, HR
Angela Pietrofeso
Vice President, Clinical Development Operations
Mary Breitmeyer
Vp, Technical Operations & Alliance Management
